Search research articles
Contact Us
Filters
Showing results (1-10 of 83) with videos related to
Page
of 9
Sort By:
Current Opinion in Oncology
|
April 21, 2011
How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?
Sylvie Lorenzen, Florian Lordick
Deutsche Medizinische Wochenschrift (1946)
|
August 15, 2024
[What's new in gastric cancer?]
Michael Masetti, Sylvie Lorenzen
Drugs & Aging
|
January 26, 2019
Treatment of Patients with Advanced Gastroesophageal Adenocarcinoma: Does Age Matter?
Sylvie Lorenzen, Ralf-Dieter Hofheinz
Expert Review of Anticancer Therapy
|
June 3, 2015
Ramucirumab as second-line treatment for patients with metastatic esophagogastric adenocarcinoma
Ralf-Dieter Hofheinz, Sylvie Lorenzen
Oncology Research and Treatment
|
April 30, 2018
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies
Maria Alsina, Markus Moehler, Sylvie Lorenzen
Hematology/Oncology Clinics of North America
|
May 15, 2017
Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?
Salah-Eddin Al-Batran, Sylvie Lorenzen
Oncology Research and Treatment
|
February 27, 2022
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma
Michael Masetti, Martin Lindinger, Sylvie Lorenzen
Current Opinion in Oncology
|
May 24, 2023
Neoadjuvant and adjuvant approaches in gastroesophageal cancers
Magdalena K Scheck, Michael Masetti, Sylvie Lorenzen
Cancers
|
July 14, 2023
HER-2-Positive Tumors: A Continuously Evolving Field in Cancer Research
Ralf Hofheinz, Sylvie Lorenzen, Michael K Bohlmann
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
August 13, 2021
[Modern concepts of systemic treatment for adjuvant and palliative treatment of locally advanced or metastasized esophageal cancer]
Sylvie Lorenzen, Anke Reinacher-Schick, Michael Masetti
Page
of 9
Search research articles
Search
Showing results (1-10 of 83) with videos related to
Sort By:
Page
of 9
Current Opinion in Oncology
|
April 21, 2011
How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?
Sylvie Lorenzen, Florian Lordick
Deutsche Medizinische Wochenschrift (1946)
|
August 15, 2024
[What's new in gastric cancer?]
Michael Masetti, Sylvie Lorenzen
Drugs & Aging
|
January 26, 2019
Treatment of Patients with Advanced Gastroesophageal Adenocarcinoma: Does Age Matter?
Sylvie Lorenzen, Ralf-Dieter Hofheinz
Expert Review of Anticancer Therapy
|
June 3, 2015
Ramucirumab as second-line treatment for patients with metastatic esophagogastric adenocarcinoma
Ralf-Dieter Hofheinz, Sylvie Lorenzen
Oncology Research and Treatment
|
April 30, 2018
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies
Maria Alsina, Markus Moehler, Sylvie Lorenzen
Hematology/Oncology Clinics of North America
|
May 15, 2017
Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?
Salah-Eddin Al-Batran, Sylvie Lorenzen
Oncology Research and Treatment
|
February 27, 2022
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma
Michael Masetti, Martin Lindinger, Sylvie Lorenzen
Current Opinion in Oncology
|
May 24, 2023
Neoadjuvant and adjuvant approaches in gastroesophageal cancers
Magdalena K Scheck, Michael Masetti, Sylvie Lorenzen
Cancers
|
July 14, 2023
HER-2-Positive Tumors: A Continuously Evolving Field in Cancer Research
Ralf Hofheinz, Sylvie Lorenzen, Michael K Bohlmann
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
August 13, 2021
[Modern concepts of systemic treatment for adjuvant and palliative treatment of locally advanced or metastasized esophageal cancer]
Sylvie Lorenzen, Anke Reinacher-Schick, Michael Masetti
Page
of 9